About Quidel
Quidel is a leading healthcare company that specializes in developing and commercializing point-of-care diagnostic tests for the detection of specific disease conditions. The company's mission is to improve healthcare decision-making and outcomes by providing accurate, reliable, and easy-to-use diagnostic solutions.
With over 40 years of experience in the industry, Quidel has established itself as a trusted provider of innovative diagnostic products. The company's portfolio includes a wide range of rapid diagnostic tests for infectious diseases, cardiac markers, women's health, gastrointestinal diseases, and more.
One of Quidel's key strengths is its focus on point-of-care testing (POCT). POCT refers to medical testing that can be performed at or near the site where patient care is provided. This approach offers several advantages over traditional laboratory-based testing. For example, POCT can provide faster results which can lead to quicker diagnosis and treatment decisions. It also allows for more convenient testing options for patients who may not have easy access to laboratory facilities.
Quidel has been at the forefront of POCT innovation since its inception. The company was one of the first to develop rapid influenza tests that could be used in physician offices and urgent care centers. Today, Quidel continues to expand its product offerings with new technologies such as molecular diagnostics and digital immunoassays.
In addition to its focus on innovation, Quidel places a strong emphasis on quality control and regulatory compliance. The company operates under strict quality management systems that are certified by international standards organizations such as ISO 13485:2016. Its products are also subject to rigorous regulatory review by agencies such as the US Food & Drug Administration (FDA) before they can be marketed.
Quidel's commitment to quality has earned it numerous accolades over the years including recognition from industry publications such as Medical Design & Outsourcing magazine which named it one of "10 Notable IVD Companies" in 2020.
Another key aspect of Quidel's business model is its partnerships with other healthcare companies and organizations. By collaborating with other experts in the field, Quidel is able to leverage their collective knowledge and resources towards common goals such as improving patient outcomes or advancing scientific research.
For example, in 2020 Quidel announced a partnership with Beckman Coulter Life Sciences aimed at developing new assays for use on Beckman Coulter's automated immunoassay platforms. This collaboration will allow both companies to expand their product offerings while leveraging each other's expertise in different areas.
Overall, Quidel stands out among healthcare companies due to its focus on innovation, quality control/regulatory compliance,and collaborative partnerships within the industry.Its dedication towards providing accurate,reliable,and easy-to-use diagnostic solutions makes it an ideal partner for physicians,hospitals,laboratories,and patients alike.Quidel continues pushing boundaries through researches so we expect even greater things from them soon!